Insulin replacement prevents the acquisition but not the expression of morphine-induced conditioned place preference in streptozotocin-induced diabetic rats

Autores

  • Rezvan Hassanpour Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran,
  • Atieh Chizar Pharmacology and Toxicology Department, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Amir-Hossein Bayat Department of Neuroscience & Psychiatry, Saveh University of Medical Sciences, Saveh, Iran,
  • Ronak Azizbeigi Department of Basic Sciences, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran
  • Zahra Mousavi Pharmacology and Toxicology Department, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  • Abbas Haghparast Neuroscience Research Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran https://orcid.org/0000-0003-1084-180X
  • Atieh Chizari Pharmacology and Toxicology Department, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

DOI:

https://doi.org/10.1590/s2175-97902022e201215

Palavras-chave:

Reward, Diabetes, Insulin replacement, Morphine, Conditioned place preference, Rat

Resumo

Insulin receptors have distributed in all brain regions, including the nucleus Accumbens (NAc), and where is implicated in the reward properties of drugs. It is well known that insulin signaling can regulate dopamine release. Therefore, in the present study, we tried to examine the effect of insulin replacement on the acquisition and expression of morphine-induced conditioned place preference (CPP) in diabetic rats. Forty-eight male Wistar rats were divided into two non-diabetic (Naïve) and diabetic groups rendered by a single injection of streptozotocin (STZ). These groups separately received insulin (10U/kg) or saline (1 ml/kg) one hour prior to morphine administration (5mg/kg;s.c.) during conditioning days (acquisition phase) or post-conditioning day (expression phase) in the CPP paradigm. In this paradigm, conditioning score (CS) and locomotion activity were recorded by Ethovision. The STZ-induced diabetic rats displayed higher CS compared to naïve rats (P<0.05). This effect was abolished in all diabetic rats that received insulin during conditioning days but not the expression phase. This study has provided evidence that insulin plays a modulatory role in morphine-induced CPP, and insulin replacement during the acquisition phase could reduce the rewarding properties of morphine in diabetes conditions through a possible modulating effect on dopamine release in the NAc region.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

American-Diabetes-Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2014;37( Suppl 1):S81-S90.

Baldo B A, Daniel R A, Berridge C W, Kelley A E. Overlapping distributions of orexin/hypocretin- and dopamine-β-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol. 2003;464(2):220-237.

Baluchnejadmojarad T, Roghani M. Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress. Behav Brain Res. 2011;224(2):305-310.

Bayat A-H, Haghparast A. Effect of insulin deficiency on the rewarding properties of methamphetamine in streptozotocin-induced diabetic rats. Pharmacol Biochem Behav. 2015;128(Supplement C):8-13.

Bruijnzeel A W, Corrie L W, Rogers J A, Yamada H. Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats. Behav Brain Res . 2011;219(2):254-264.

Carvelli L, Morón J A, Kahlig K M, Ferrer J V, Sen N, Lechleiter J D, et al. PI 3-kinase regulation of dopamine uptake. J. Neurochem. 2002;81(4):859-869.

Castro D C, Berridge K C. Opioid Hedonic Hotspot in Nucleus Accumbens Shell: Mu, Delta, and Kappa Maps for Enhancement of Sweetness “Liking” and “Wanting”. J Neurosci. 2014;34(12):4239.

Cruz B, Flores R J, Uribe K P, Espinoza E J, Spencer C T, Serafine K M, et al. Insulin modulates the strong reinforcing effects of nicotine and changes in insulin biomarkers in a rodent model of diabetes. Neuropsychopharmacology. 2019;44(6):1141-1151.

Davis J F, Choi D L, Benoit S C. Insulin, leptin and reward. Trends Endocrinol Metab. 2010;21(2):68-74.

Daws L C, Avison M J, Robertson S D, Niswender K D, Galli A, Saunders C. Insulin signaling and addiction. Neuropharmacology. 2011;61(7):1123-1128.

Doolen S, Zahniser N R. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J Pharmacol Exp Ther. 2001;296(3):931-938.

Eccles M P, Hrisos S, Francis J J, Stamp E, Johnston M, Hawthorne G, et al. Instrument development, data collection, and characteristics of practices, staff, and measures in the Improving Quality of Care in Diabetes (iQuaD) Study. Implement Sci. 2011;6(1):61.

Edalat P, Kavianpour M, Zarrabian S, Haghparast A. Role of orexin-1 and orexin-2 receptors in the CA1 region of hippocampus in the forced swim stress- and food deprivation-induced reinstatement of morphine seeking behaviors in rats. Brain Res Bull. 2018;142:25-32.

Fadel J, Deutch A Y. Anatomical substrates of orexin- dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neurosci. 2002;111(2):379-387.

Fatahi Z, Zibaii M I, Haghparast A. Effect of acute and subchronic stress on electrical activity of basolateral amygdala neurons in conditioned place preference paradigm: An electrophysiological study. Behav Brain Res . 2017;335(Suppl C):19-25.

Ferrario C R, Reagan L P. Insulin-mediated synaptic plasticity in the CNS; Anatomical, functional and temporal contexts. Neuropharmacology . 2018;136(Pt B):182-191. doi: 10.1016/j.neuropharm. 2017.12.001.

» https://doi.org/10.1016/j.neuropharm. 2017.12.001.

Figlewicz D P. Insulin, food intake, and reward. Paper presented at the Seminars in clinical neuropsychiatry. Semin Clin Neuropsychiatry. 2003;8(2):82-93.

Furman B L. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol. 2015;70:5.47.1-5.47.20.

Galici R, Galli A, Jones D J, Sanchez T A, Saunders C, Frazer A, et al. Selective Decreases in Amphetamine Self-Administration and Regulation of Dopamine Transporter Function in Diabetic Rats. Neuroendocrinology. 2003;77(2):132-140.

Garcia B, Wei Y, Moron J, Lin R, Javitch J, Galli A. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol. 2005;68(1):102-109.

Giros B, Jaber M, Jones S R, Wightman R M, Caron M G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996;379(6566):606-612.

Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature. 1978;272(5656):827-829.

Íbias J, O’Dell L E, Nazarian A. Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes. Behav Brain Res . 2018;351:75-82.

Junod A, Lambert A E, Orci L, Pictet R, Gonet A E, Renold A E. Studies of the Diabetogenic Action of Streptozotocin. Exp Biol Med. 1967;126(1):201-205.

Kahlig K M, Galli A. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur J Pharmacol. 2003;479(1):153-158.

Karimi-Haghighi S, Haghparast A. Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats. Prog Neuropsychopharmacol Biol Psychiatry. 2018;82:307-313.

Klawonn A M, Malenka R C. Nucleus Accumbens Modulation in Reward and Aversion. Cold Spring Harb Symp Quant Biol. 2018;83:119-129.

Koob G F, Bloom F E. Cellular and molecular mechanisms of drug dependence. Science. 1988;242(4879):715-723.

Labouèbe G, Liu S, Dias C, Zou H, Wong J C, Karunakaran S, et al. insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat Neurosci . 2013;16(3):300-308.

Lauretta M, Tewari A, Hara N, Hiroyuki U, Rosa G, Bilotta F. Insulin and brain: a sweet relationship, a systematic review: 7AP3-4. Eur J Anaesthesiol. 2014;31(52):115.

Margolis R U, Altszuler N. Insulin in the cerebrospinal fluid. Nature. 1967;215(5108):1375-1376.

Mebel D, Wong J, Dong Y, Borgland S. Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake. Eur J Neurosci . 2012;36(3):2336-2346.

O’Dell L E, Nazarian A. Enhanced vulnerability to tobacco use in persons with diabetes: A behavioral and neurobiological framework. Prog Neuropsychopharmacol Biol Psychiatry . 2016;65(Suppl C):288-296.

Owens W A, Sevak R J, Galici R, Chang X, Javors M A, Galli A, et al. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem. 2005;94(5):1402-1410.

Plum L, Schubert M, Brüning J C. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab . 2005;16(2):59-65.

Pontieri F E, Tanda G, Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the “shell” as compared with the “core” of the rat nucleus accumbens. Proc Natl Acad Sci. 1995;92(26):12304-12308.

Sahafzadeh M, Karimi-Haghighi S, Mousavi Z, Haghparast A. Role of the orexin receptors within the nucleus accumbens in the drug priming-induced reinstatement of morphine seeking in the food deprived rats. Brain Res Bull. 2018;137:217-224.

Samandari R, Chizari A, Hassanpour R, Mousavi Z, Haghparast A. Streptozotocin-induced diabetes affects the development and maintenance of morphine reward in rats. Neurosci Lett. 2013;543:90-94.

Schulingkamp R J, Pagano T C, Hung D, Raffa R B. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev. 2000;24(8):855-872.

Schwartz M W, Sipols A, Kahn S E, Lattemann D F, Taborsky G, Bergman R N, et al. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol Endocrinol Metab. 1990;259(3):E378.

Sevak R J, Koek W, Galli A, France C P. Insulin Replacement Restores the Behavioral Effects of Quinpirole and Raclopride in Streptozotocin-Treated Rats. J Pharmacol Exp Ther. 2007;320(3):1216.

Stouffer M A, Woods C A, Patel J C, Lee C R, Witkovsky P, Bao L, et al. insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward. Nat Commun. 2015;6:8543.

Tuominen L, Tuulari J, Karlsson H, Hirvonen J, Helin S, Salminen P, et al. Aberrant mesolimbic dopamine-opiate interaction in obesity. NeuroImage. 2015;122:80-86.

Vogt M C, Brüning J C. CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age. Trends Endocrinol Metab . 2013;24(2):76-84.

Williams J M, Owens W A, Turner G H, Saunders C, Dipace C, Blakely R D, et al. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS biology. 2007;5(10):e274.

Wise R A, Bozarth M A. A psychomotor stimulant theory of addiction. Psychol Rev. 1987;94(4):469.

Woods S C, Porte D. Relationship between plasma and cerebrospinal fluid insulin levels of dogs. Am J Physiol Gastrointest Liver Physiol. 1977;233(4):G331-G334.

Downloads

Publicado

2022-12-23

Edição

Seção

Original Article

Como Citar

Insulin replacement prevents the acquisition but not the expression of morphine-induced conditioned place preference in streptozotocin-induced diabetic rats. (2022). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e201215